Quest Diagnostics Incorporated
HealthcareNYSE:DGX · New York Stock Exchange
-$0.97 today
Vol 0.66M · Avg 0.89M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $393.0M |
| Receivables | $1.6B |
| Inventory | $225.0M |
| Other Current | $361.0M |
| Total Current Assets | $2.6B |
| PP&E (Net) | $2.9B |
| Goodwill | $9.1B |
| Intangible Assets | $1.7B |
| Long-term Investments | $134.0M |
| Other Non-current | $256.0M |
| Total Non-current Assets | $14.1B |
| Total Assets | $16.7B |
Analysis
Selected assets total $16.7B for Latest. The largest visible component is Goodwill at $9.1B, about 54.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $420.0M -23.5% | $549.0M -20.0% | $686.0M +117.8% | $315.0M -63.9% | $872.0M | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $1.4B +8.0% | $1.3B +7.8% | $1.2B +1.3% | $1.2B -16.9% | $1.4B | $533.8M | $399.4M | -$1.7B |
| Inventory | $189.0M +0.5% | $188.0M -1.1% | $190.0M -1.0% | $192.0M -7.7% | $208.0M | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $361.0M +2.8% | $351.0M +22.7% | $286.0M +45.9% | $196.0M | $0 | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $2.4B -0.6% | $2.4B +0.8% | $2.4B +25.0% | $1.9B -30.8% | $2.7B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $2.9B +3.5% | $2.8B +14.3% | $2.4B +2.8% | $2.4B +2.0% | $2.3B | $1.2B | $1.5B | $687.8M |
| Goodwill | $8.9B +1.0% | $8.9B +14.5% | $7.7B +7.1% | $7.2B +1.8% | $7.1B | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $1.6B -7.2% | $1.8B +51.2% | $1.2B +6.8% | $1.1B -6.4% | $1.2B | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $136.0M +10.6% | $123.0M -8.9% | $135.0M +2.3% | $132.0M -6.4% | $141.0M | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $0 | $0 | $0 | $0 | $0 | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $270.0M +5.9% | $255.0M +28.8% | $198.0M +37.5% | $144.0M -11.7% | $163.0M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $13.8B +0.6% | $13.8B +18.1% | $11.7B +6.5% | $10.9B +0.6% | $10.9B | -$15.3B | $14.8B | $11.3B |
| Total Assets | $16.2B +0.4% | $16.2B +15.2% | $14.0B +9.2% | $12.8B -5.7% | $13.6B | $13.3B | $11.9B | $10.6B |
| Account Payables | $1.6B +457.5% | $287.0M -24.1% | $378.0M +16.7% | $324.0M -9.2% | $357.0M | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $678.0M -27.6% | $937.0M +60.2% | $585.0M +136.8% | $247.0M -8.2% | $269.0M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 | $0 | $0 -100.0% | $2.0M -80.0% | $10.0M | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $0 -100.0% | $466.0M -1.1% | $471.0M -14.4% | $550.0M -8.2% | $599.0M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $2.3B +5.0% | $2.2B +19.5% | $1.8B +17.0% | $1.6B -11.5% | $1.8B | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $5.7B +1.9% | $5.6B +27.0% | $4.4B +10.9% | $4.0B -0.8% | $4.0B | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $0 -100.0% | $250.0M -7.4% | $270.0M -8.5% | $295.0M +1.7% | $290.0M | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $420.0M -39.0% | $688.0M +13.5% | $606.0M +17.2% | $517.0M +3.0% | $502.0M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $6.7B -6.0% | $7.1B +22.4% | $5.8B +9.7% | $5.3B -0.3% | $5.3B | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $8.9B -3.4% | $9.3B +21.7% | $7.6B +11.3% | $6.8B -3.1% | $7.0B | $14.7B | $3.7B | $9.6B |
| Common Stock | $2.0M +0.0% | $2.0M +0.0% | $2.0M +0.0% | $2.0M +0.0% | $2.0M | $651.4M | $517.0M | $382.6M |
| Retained Earnings | $10.0B +6.8% | $9.4B +6.1% | $8.8B +6.5% | $8.3B +8.4% | $7.6B | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | -$27.0M +69.3% | -$88.0M -528.6% | -$14.0M +33.3% | -$21.0M -50.0% | -$14.0M | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $116.0M -1.7% | $118.0M +6.3% | $111.0M -2.6% | $114.0M -3.4% | $118.0M | $1.4B | $337.8M | $931.4M |
| Total Equity | $7.3B +5.7% | $6.9B +7.4% | $6.4B +6.8% | $6.0B -8.5% | $6.6B | $9.1B | $7.7B | $3.3B |
| Total Debt | $6.9B -2.4% | $7.1B +28.9% | $5.5B +16.6% | $4.7B -1.2% | $4.8B | $724.2M | $410.6M | $399.4M |
| Net Debt | $6.5B -0.6% | $6.5B +35.9% | $4.8B +9.4% | $4.4B +12.8% | $3.9B | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Illumina, Inc.
NASDAQ:ILMN
$24.40B
West Pharmaceutical Services, Inc.
NYSE:WST
$23.28B
Waters Corporation
NYSE:WAT
$23.18B
United Therapeutics Corporation
NASDAQ:UTHR
$22.97B
Incyte Corporation
NASDAQ:INCY
$21.79B
Labcorp Holdings Inc.
NYSE:LH
$21.65B
Zimmer Biomet Holdings, Inc.
NYSE:ZBH
$17.13B
Tenet Healthcare Corporation
NYSE:THC
$15.27B
Medpace Holdings, Inc.
NASDAQ:MEDP
$13.42B
ICON Public Limited Company
NASDAQ:ICLR
$11.16B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does DGX have?
Quest Diagnostics Incorporated (DGX) reported $420.00M in cash and equivalents in fiscal 2025.
How much debt does DGX carry?
Quest Diagnostics Incorporated (DGX) reported $6.92B of total debt, with net debt of $6.50B.
Explore More
Continue the stock analysis
Jump to another research area for this company.